Table 2.
Quantitative acceptability and feasibility measures
| Variable – n (%)a | Group PM+ | EUC |
|---|---|---|
| Acceptability of intervention | n = 4 | n = 4 |
| Competency in common factors (%, IQR) | ||
| Pre-training in psychosocial foundations | 23% (11–44%) | 27% (11–61%) |
| Post-training in psychosocial foundations | 76% (61–89%) | 84% (72–94%) |
| Fidelity of PM+ facilitators | ||
| To 75% or more items in each of 5 group sessions | 4 (100%) | – |
| To 75% or more items in more than 3 group sessions | 4 (100%) | – |
| Group PM+ participation | n = 61 | n = 60 |
| Number of sessions attended | – | |
| 0 | 2 (3%) | – |
| 1 | 3 (5%) | – |
| 2 | 0 (0%) | – |
| 3 | 10 (16.4%) | – |
| 4 | 14 (23.0%) | – |
| 5 | 32 (52.5%) | – |
| – | ||
| Outcome measurements | n = 61 | n = 60 |
| All items of outcome measured at baselineb | ||
| PHQ-9 | 61 (100%) | 60 (100%) |
| WHODAS | 61 (100%) | 60 (100%) |
| GHQ | 61 (100%) | 60 (100%) |
| PCL-5 | 61 (100%) | 60 (100%) |
| RTC | 61 (100%) | 60 (100%) |
| All items of outcome measured at endlineb,c | ||
| PHQ-9 | 58 (100%) | 60 (100%) |
| WHODAS | 58 (100%) | 60 (100%) |
| GHQ | 58 (100%) | 60 (100%) |
| PCL-5 | 58 (100%) | 60 (100%) |
| RTC | 58 (100%) | 60 (100%) |
| All key outcomes measuredb | ||
| Baseline | 61 (100%) | 60 (100%) |
| Endlinec | 58 (100%) | 60 (100%) |
| Time (days) between: [median (25th, 75th percentile)] | ||
| Screening and baseline interview | 10 (5, 32) | 9 (6, 14) |
| Baseline interview and endline interviewc | 42 (36, 47) | 48 (43, 52) |
| Adverse events | ||
| Any adverse eventd | 4 | 2 |
| Serious adverse event | 0 | 1e |
a
Unless otherwise noted.
b
Of five key measures: PHQ-9, WHODAS, GHQ, PCL-5 and RTC. Note, at baseline, WHODAS and GHQ were measured at screening and the remaining three measures at the baseline interview. Additionally, there were no missing items for any of the five measures at either time point.
c
Of those who were not lost to follow-up (n = 58 in intervention and n = 60 in control).
d
All six were suicidal thoughts.
e
Death unrelated to the study.